Humacyte HUMA
NASDAQ HUMA
$0.52 -0.01 (-1.89%)
At close: Sep 30, 2026 · 4:00 PM EDT

Humacyte (HUMA) Non Operating Interest Expenses (2020 - 2026)

Updated

Humacyte (HUMA) recorded Non Operating Interest Expenses of $2.32 million in Q2 2026, down 8.8% from $2.55 million a year earlier but up 2.2% from the prior quarter.

Analysis

Humacyte (HUMA) Non Operating Interest Expenses (2020 - 2026) Analysis & Trends

On a TTM basis, Humacyte's Non Operating Interest Expenses came in at $10.3 million as of Jun 30, 2026, down 1.8% year-over-year; for FY2025, it came in at $11.25 million, up 21.3% from FY2024.

  • Annual Non Operating Interest Expenses has increased for five straight years, with a five-year compound annual growth rate of 38.6% (FY2020 to FY2025).
  • Across earlier years, Non Operating Interest Expenses came in at $9.28 million in FY2024 (+40.6%), $6.6 million in FY2023 (+6.4%), $6.2 million in FY2022 (+42.6%) and $4.35 million in FY2021 (+97.5%).
  • Quarterly Non Operating Interest Expenses has ranged from $1.2 million in Q3 2021 to $3.09 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Non Operating Interest Expenses rose in six of the last eight quarters, with growth averaging 22.0%.
  • Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 168.7% in Q1 2022, against a decline of 24.3% in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.27 million (Q1 2026), $3.09 million (Q4 2025) and $2.61 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Humacyte 144.46 Mn 144.46 Mn -825,000.00 2.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.32 Mn
Mar 31, 2026 2.27 Mn
Dec 31, 2025 3.09 Mn
Sep 30, 2025 2.61 Mn
Jun 30, 2025 2.55 Mn
Mar 31, 2025 3.00 Mn
Dec 31, 2024 2.51 Mn
Sep 30, 2024 2.44 Mn
Jun 30, 2024 2.52 Mn
Mar 31, 2024 1.82 Mn
Dec 31, 2023 1.73 Mn
Sep 30, 2023 1.46 Mn
Jun 30, 2023 1.71 Mn
Mar 31, 2023 1.70 Mn
Dec 31, 2022 1.64 Mn
Sep 30, 2022 1.64 Mn
Jun 30, 2022 1.49 Mn
Mar 31, 2022 1.43 Mn
Dec 31, 2021 1.40 Mn
Sep 30, 2021 1.20 Mn
API Access

Humacyte Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=HUMA&period=max&api_key=YOUR_API_KEY